Donnay L, Dejean C, Amsellem E, Bourezgui H, de Figueiredo B H, Duparc A, Caron J, Tournat H, Lagarde P, Stoeckle E, Kantor G
Département de radiothérapie, centre régional de lutte contre le cancer, 229, cours de l'Argonne, 33076 Bordeaux cedex, France.
Cancer Radiother. 2008 Dec;12(8):809-16. doi: 10.1016/j.canrad.2008.08.275. Epub 2008 Nov 28.
To evaluate dosimetry of helicoidal tomotherapy versus three-dimensional conformal radiotherapy (3D-CRT) with and without IMRT for the treatment of soft tissue sarcoma (STS) of the thigh.
A retrospective study was performed for three patients who received 3D-CRT as adjuvant radiation therapy for STS of the thigh. These three patients had a tumor in posterior, adductor or anterior compartment of the thigh. In each case, three treatments plans were optimised in tomotherapy, without bloc, with directional bloc and complete bloc of controlateral limb, to adequately treat the planning target volume and spare organ at risk. For each patient, we compare the three modalities of tomotherapy or "classical" IMRT from a clinac with the 3D-CRT actually performed for the treatment.
Tomotherapy provides improved PTV coverage and dose homogeneity. This benefit was comparable in the three tomotherapy plans. The average D95% for tomotherapy and 3D-CRT were 97.6% and 94.8% respectively and the standard deviation is, at least, divided by two with conformal and is always better than performed with a clinac. The volume of the surrounding soft tissues receiving at least full prescription and hot spots, as evaluated by D2%, were significantly reduced in tomotherapy. Nevertheless, the results concerning the skin, the femur and the gonads were dependent on the tumor site in the thigh and not always improved with tomotherapy dosimetric studies.
For this preliminary study, tomotherapy can provide better coverage and dose uniformity in PTV and minimize the volume of surrounding muscular tissues receiving high doses. However, in this study, there is no benefit for others OAR (skin, femur and gonads) except in particular constraint (for instance for a precise sparing of cutaneous or bony area). Other dosimetric studies, followed by prospective evaluations with long-term follow-up are needed to determine whether tomotherapy can improve outcome for patients with STS of the thigh.
评估螺旋断层放射治疗与三维适形放射治疗(3D-CRT)联合或不联合调强放射治疗(IMRT)用于治疗大腿软组织肉瘤(STS)的剂量学情况。
对3例接受3D-CRT作为大腿STS辅助放射治疗的患者进行回顾性研究。这3例患者的肿瘤位于大腿后侧、内收肌或前侧间隙。每种情况下,在断层放射治疗中优化了3种治疗计划,分别为无遮挡、有定向遮挡和对侧肢体完全遮挡,以充分治疗计划靶体积并保护危及器官。对于每位患者,我们将断层放射治疗的3种模式或直线加速器的“经典”IMRT与实际用于治疗的3D-CRT进行比较。
断层放射治疗可改善计划靶体积(PTV)覆盖和剂量均匀性。这种益处在3种断层放射治疗计划中相当。断层放射治疗和3D-CRT的平均D95%分别为97.6%和94.8%,标准差至少减半,适形放疗的标准差始终优于直线加速器放疗。通过D2%评估,接受至少全处方剂量的周围软组织体积和热点在断层放射治疗中显著减少。然而,关于皮肤、股骨和性腺的结果取决于大腿肿瘤部位,且在剂量学研究中,断层放射治疗并不总是能改善这些结果。
对于这项初步研究,断层放射治疗可在PTV中提供更好的覆盖和剂量均匀性,并使接受高剂量的周围肌肉组织体积最小化。然而,在本研究中,除了特定限制(例如精确保护皮肤或骨区域)外,对其他危及器官(皮肤、股骨和性腺)并无益处。需要进行其他剂量学研究,并进行长期随访的前瞻性评估,以确定断层放射治疗是否能改善大腿STS患者的治疗结果。